Bullfrog AI (NASDAQ:BFRG – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.
Volatility and Risk
Bullfrog AI has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500.
Insider and Institutional Ownership
1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 25.2% of Bullfrog AI shares are held by insiders. Comparatively, 24.1% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bullfrog AI | $60,000.00 | 120.76 | -$6.99 million | ($0.69) | -0.92 |
| Clover Health Investments | $1.92 billion | 0.54 | -$85.55 million | ($0.17) | -11.85 |
Bullfrog AI has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Bullfrog AI and Clover Health Investments, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bullfrog AI | 1 | 0 | 0 | 0 | 1.00 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
Clover Health Investments has a consensus price target of $3.07, indicating a potential upside of 52.19%. Given Clover Health Investments’ stronger consensus rating and higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Bullfrog AI.
Profitability
This table compares Bullfrog AI and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bullfrog AI | N/A | -218.25% | -177.11% |
| Clover Health Investments | -4.45% | -25.17% | -14.81% |
Summary
Clover Health Investments beats Bullfrog AI on 9 of the 14 factors compared between the two stocks.
About Bullfrog AI
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.
